Franklin Resources Inc Amylyx Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.71 - $19.57 $1.44 Million - $10.4 Million
530,885 Added 40.07%
1,855,886 $5.27 Million
Q4 2023

Feb 09, 2024
BUY
$12.07 - $18.46 $8.54 Million - $13.1 Million
707,134 Added 114.45%
1,325,001 $19.5 Million
Q3 2023

Nov 13, 2023
BUY
$18.08 - $23.45 $10.7 Million - $13.8 Million
589,381 Added 2069.02%
617,867 $11.3 Million
Q2 2023

Aug 11, 2023
BUY
$20.98 - $31.42 $597,636 - $895,030
28,486 New
28,486 $614,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email